Lawrence K M, De Paermentier F, Cheetham S C, Crompton M R, Katona C L, Horton R W
Department of Pharmacology and Clinical Pharmacology, St. George's Hospital Medical School, London, U.K.
Brain Res. 1990 Aug 27;526(1):17-22. doi: 10.1016/0006-8993(90)90244-6.
Brain serotonin (5-HT) uptake sites were quantitated, by saturation binding of [3H]paroxetine, in 10 brain regions from 22 suicide victims and 20 control subjects. Suicide victims were restricted to those subjects in whom a firm retrospective diagnosis of depression was established and who had not recently been prescribed antidepressant drugs. The Kd and Bmax of [3H]paroxetine did not differ significantly between controls and depressed suicides in any of the brain regions. In putamen, Bmax values of suicides who died non-violently were lower than controls, whereas those who died by violent methods did not differ from controls. No significant differences between violent or non-violent suicides and their matched controls were found in other brain areas. These results offer little support for the view that suicide/depression is associated with an abnormality in 5-HT uptake.
通过[3H]帕罗西汀的饱和结合,对22名自杀受害者和20名对照者的10个脑区中的脑血清素(5-羟色胺,5-HT)摄取位点进行了定量分析。自杀受害者仅限于那些经回顾性诊断确诊为抑郁症且近期未服用过抗抑郁药物的个体。在任何脑区中,对照者和抑郁自杀者之间[3H]帕罗西汀的解离常数(Kd)和最大结合容量(Bmax)均无显著差异。在壳核中,非暴力死亡的自杀者的Bmax值低于对照者,而暴力死亡的自杀者与对照者无差异。在其他脑区,暴力或非暴力自杀者与其匹配的对照者之间未发现显著差异。这些结果几乎不支持自杀/抑郁症与5-HT摄取异常有关的观点。